Detection of human aspartyl (asparaginyl) beta-hydroxylase and homeobox B7 mRNA in brush cytology specimens from patients with bile duct cancer

Endoscopy

Volumn 38, Issue 6, 2006, Pages 604-609

  Feldmann, G ^a   Nattermann, J ^a   Nischalke, H D ^a   Gorschluter M ^a   Kuntzen, T ^a   Ahlenstiel, G ^a   Gerhardt, T ^a   Wolff, M ^a   Sauerbruch, T ^a   Spengler, U ^a   Dumoulin, F L ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTYL (ASPARAGINYL) OXYGENASE; HOMEODOMAIN PROTEIN; HOMEODOMAIN PROTEIN B7; MESSENGER RNA; OXYGENASE; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BILE DUCT CANCER; BILE DUCT CARCINOMA; BILE DUCT OBSTRUCTION; BIOPSY TECHNIQUE; CANCER CELL CULTURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC ACCURACY; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REFERENCE VALUE; REPRODUCIBILITY; RNA EXTRACTION; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CELL LINE, TUMOR; CHOLANGIOCARCINOMA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; MALE; MIDDLE AGED; MIXED FUNCTION OXYGENASES; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 33745548416     PISSN: 0013726X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-925065     Document Type: Article

References (23)

1. De Groen PC, Gores GJ, LaRusso NF et al. Biliary tract cancers. N Engl J Med 1999; 341: 1368-1378
2. Wiedmann M, Berr F, Schiefke I et al. Photodynamic therapy in patients with non-resectable hilar cholangiocarcinoma: 5-year follow-up of a prospective phase II study. Gastrointest Endosc 2004; 60: 68-75
3. De Bellis M, Sherman S, Fogel EL et al. Tissue sampling at ERCP in suspected malignant biliary strictures (part 2). Gastrointest Endosc 2002; 56: 720-730
4. Principe A, Ercolani G, Bassi F et al. Diagnostic dilemmas in biliary strictures mimicking cholangiocarcinoma. Hepatogastroenterology 2003; 50: 1246-1249
5. Hansel DE, Rahman A, Hidalgo M et al. Identification of novel cellular targets in biliary tract cancers using global gene expression technology. Am J Pathol 2003; 163: 217-229
6. Enjoji M, Kotoh K, Iwamoto H et al. Self-regulation of type I collagen degradation by collagen-induced production of matrix metalloproteinase-1 on cholangiocarcinoma and hepatocellular carcinoma cells. In Vitro Cell Dev Biol Anim 2000; 36: 71-73
7. Lopes Cardozo P. Atlas of clinical cytology: a contribution to precise cytodiagnosis and cytological differential diagnosis. Leiden, Netherlands: s. l., c. 1976
8. Kocjan G, Smith AN. Bile duct brushings cytology: potential pitfalls in diagnosis. Diagn Cytopathol 1997; 16: 358-363
9. Dumoulin FL, Nischalke HD, Leifeld L et al. Semi-quantification of human C-C chemokine mRNAs with reverse transcription/real-time PCR using multi-specific standards. J Immunol Methods 2000; 241: 109-119
10. Morales CP, Burdick JS, Saboorian MH et al. In situ hybridization for telomerase RNA in routine cytologic brushings for the diagnosis of pancreaticobiliary malignancies. Gastrointest Endosc 1998; 48: 402-405
11. Itoi T, Shinohara Y, Takeda K et al. Detection of telomerase activity in biopsy specimens for diagnosis of biliary tract cancers. Gastrointest Endosc 2000; 52: 380-386
12. Niiyama H, Mizumoto K, Kusumoto M et al. Activation of telomerase and its diagnostic application in biopsy specimens from biliary tract neoplasms. Cancer 1999; 85: 2138-2143
13. Ponsioen CY, Vrouenraets SM, van Milligen de Wit AW et al. Value of brush cytology for dominant strictures in primary sclerosing cholangitis. Endoscopy 1999; 31: 305-309
14. Stewart CJ, Burke GM. Value of p53 immunostaining in pancreaticobiliary brush cytology specimens. Diagn Cytopathol 2000; 23: 308-313
15. Kipp BR, Stadheim LM, Halling SA et al. A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures. Am J Gastroenterol 2004; 99: 1675-1681
16. Khalid A, Pal R, Sasatomi E et al. Use of microsatellite marker loss of heterozygosity in accurate diagnosis of pancreaticobiliary malignancy from brush cytology samples. Gut 2004; 53: 1860-1865
17. Nehls O, Gregor M, Klump B. Serum and bile markers for cholangiocarcinoma. Semin Liver Dis 2004; 24: 139-154
18. Obama K, Ura K, Li M et al. Genome-wide analysis of gene expression in human intrahepatic cholangiocarcinoma. Hepatology 2005; 41: 1339-1348
19. Lavaissiere L, Jia S, Nishiyama M et al. Overexpression of human aspartyl(asparaginyl)beta-hydroxylase in hepatocellular carcinoma and cholangiocarcinoma. J Clin Invest 1996; 98: 1313-1323
20. Ince N, de la Monte SM, Wands JR. Overexpression of human aspartyl (asparaginyl) beta-hydroxylase is associated with malignant transformation. Cancer Res 2000; 60: 1261-1266
21. De Bellis M, Sherman S, Fogel EL et al. Tissue sampling at ERCP in suspected malignant biliary strictures (part 1). Gastrointest Endosc 2002; 56: 552-561
22. Rupp M, Hawthorne CM, Ehya H. Brushing cytology in biliary tract obstruction. Acta Cytol 1990; 34: 221-226
23. Selvaggi SM. Biliary brushing cytology. Cytopathology 2004; 15: 74-79